BUTHMAN MARK A 4

What Happened Mark A. Buthman, a director of West Pharmaceutical Services, was granted 791 restricted stock units (RSUs) on May 4, 2026. The units were issued at $0.00 (typical for compensation awards) and thus had no cash cost to Mr. Buthman at grant. The filing lists the transaction code "A" (award/grant/acquisition).

Key Details

• Transaction date: 2026-05-04; filing date: 2026-05-06 (filed within the standard two-business-day Form 4 window).
• Grant amount and price: 791 RSUs @ $0.00 (acquired via award).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnote: These RSUs will vest in full on the date of the next annual shareholder meeting.
• Transaction type: Award/compensation (code A), not an open-market purchase or sale.

Context RSU grants are a form of compensation that converts to shares when vesting conditions are met; they do not represent an immediate purchase or sale and typically signal retention/compensation rather than a direct market view. Because these units vest at the next annual meeting, they may convert into common shares on that date if vesting conditions are satisfied.